Page last updated: 2024-09-03

imatinib mesylate and Liver Cirrhosis, Biliary

imatinib mesylate has been researched along with Liver Cirrhosis, Biliary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbu, V; Francoz, C; Housset, C; Hultcrantz, R; Kinnman, N; Poupon, R; Rey, C; Wendum, D1

Other Studies

1 other study(ies) available for imatinib mesylate and Liver Cirrhosis, Biliary

ArticleYear
The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.
    Laboratory investigation; a journal of technical methods and pathology, 2003, Volume: 83, Issue:2

    Topics: Actins; Animals; Benzamides; Bile Ducts; Cell Differentiation; Cell Lineage; Collagen; Desmin; Disease Models, Animal; Fibroblasts; Imatinib Mesylate; Kupffer Cells; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Phenotype; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2003
chemdatabank.com